Inactive Instrument
HedgePath Pharmaceuticals Inc Stock
Stocks
US42278K1025
Biotechnology & Medical Research
| 1 day | -27.42% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 76 | 2022-12-12 | |
James McNulty
DFI | Director of Finance/CFO | 76 | 2022-12-12 |
Simon Bettink
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 76 | 2022-12-12 | |
Niraj Vasisht
BRD | Director/Board Member | 62 | 2022-12-12 |
Samuel Sears
BRD | Director/Board Member | 82 | 2013-08-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -27.42% | -3.08% | - | - | 32.23M | |
| +2.41% | +0.29% | +39.41% | +72.14% | 64.69B | |
| -0.15% | +7.50% | +11.42% | +71.27% | 54.78B | |
| +0.57% | +4.60% | +7.71% | +90.93% | 53.49B | |
| +0.37% | +4.67% | +26.68% | +49.64% | 45.98B | |
| -1.21% | +2.32% | +21.50% | +118.33% | 42.94B | |
| -0.37% | +5.07% | +243.23% | +789.58% | 40.08B | |
| +0.05% | +0.21% | +18.06% | +48.50% | 33.52B | |
| +1.19% | -4.98% | +26.31% | -0.76% | 23.97B | |
| -0.38% | +5.68% | +38.39% | +28.35% | 23.67B | |
| Average | -2.49% | +2.41% | +48.08% | +140.89% | 42.57B | |
| Weighted average by Cap. | +0.39% | +2.73% | +46.02% | +142.84% |
Employees
-
